MX346524B - Diagnostico de infecciones virales mediante la deteccion de adn viral genómico e infeccioso mediante compatibilización molecular. - Google Patents

Diagnostico de infecciones virales mediante la deteccion de adn viral genómico e infeccioso mediante compatibilización molecular.

Info

Publication number
MX346524B
MX346524B MX2012012352A MX2012012352A MX346524B MX 346524 B MX346524 B MX 346524B MX 2012012352 A MX2012012352 A MX 2012012352A MX 2012012352 A MX2012012352 A MX 2012012352A MX 346524 B MX346524 B MX 346524B
Authority
MX
Mexico
Prior art keywords
viral
dna
probes
detection
molecular combing
Prior art date
Application number
MX2012012352A
Other languages
English (en)
Other versions
MX2012012352A (es
Inventor
Conseiller Emmanuel
Mahiet Charlotte
Salvaire Fabrice
Barradeau Sébastien
Original Assignee
Genomic Vision
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomic Vision filed Critical Genomic Vision
Publication of MX2012012352A publication Critical patent/MX2012012352A/es
Publication of MX346524B publication Critical patent/MX346524B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/708Specific hybridization probes for papilloma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un método para detectar in vitro la presencia de un genoma de virus de ADN o un ADN derivado viral en una célula, tejido o fluido biológico eucariótico infectado, utilizando peinado molecular u otros métodos de extensión de ácido nucleico junto con sondas, especialmente sondas de ácido nucleico, que tienen un diseño especial. Se describe un método para monitorear in vitro los efectos del tratamiento anti-viral, siguiendo la presencia de los polinucleótidos de ADN virales genómicos o derivados virales en una célula, tejido o fluido biológico infectado con virus. Detección de una forma infecciosa de un virus utilizando peinado molecular e hibridación de ADN. Un equipo que comprende sondas utilizadas para llevar a cabo estos métodos y una composición que comprende de las sondas.
MX2012012352A 2010-04-23 2011-04-19 Diagnostico de infecciones virales mediante la deteccion de adn viral genómico e infeccioso mediante compatibilización molecular. MX346524B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32739710P 2010-04-23 2010-04-23
PCT/IB2011/001048 WO2011132078A2 (en) 2010-04-23 2011-04-19 Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing

Publications (2)

Publication Number Publication Date
MX2012012352A MX2012012352A (es) 2013-06-28
MX346524B true MX346524B (es) 2017-03-23

Family

ID=44511088

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012352A MX346524B (es) 2010-04-23 2011-04-19 Diagnostico de infecciones virales mediante la deteccion de adn viral genómico e infeccioso mediante compatibilización molecular.

Country Status (10)

Country Link
US (4) US20110287423A1 (es)
EP (2) EP2561104B1 (es)
JP (2) JP2013524806A (es)
CN (2) CN103069010B (es)
BR (1) BR112012027151A8 (es)
CA (1) CA2796294C (es)
ES (1) ES2668802T3 (es)
IL (2) IL222545A (es)
MX (1) MX346524B (es)
WO (1) WO2011132078A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014535050A (ja) * 2011-10-31 2014-12-25 ゲノミク ビジョン 生体試料におけるゲノム再編成を特定又は検出する方法
WO2013078302A1 (en) 2011-11-23 2013-05-30 Cornell University Methods for diagnosing human immunodeficiency virus infections
CN103074337B (zh) * 2012-12-04 2014-07-09 昆明寰基生物芯片产业有限公司 一段单纯疱疹病毒dna序列及应用
WO2015013681A1 (en) 2013-07-25 2015-01-29 Bio-Rad Laboratories, Inc. Genetic assays
CN112280792B (zh) * 2013-09-29 2022-06-24 上海泽润生物科技有限公司 人***瘤病毒基因,及载体,菌株,表达方法
CN104673796A (zh) * 2015-02-09 2015-06-03 暨南大学 靶向hsv-1病毒ul18基因的小干扰rna及应用
RU2018120004A (ru) * 2015-10-30 2019-12-02 Конинклейке Филипс Н.В. Способы, системы и процессы определения путей передачи инфекционных агентов
CN110168102A (zh) * 2016-11-15 2019-08-23 基因组影像公司 利用分子梳理监测经修饰的核酸酶诱导的基因编辑事件的方法
WO2018100431A1 (en) 2016-11-29 2018-06-07 Genomic Vision Method for designing a set of polynucleotide sequences for analysis of specific events in a genetic region of interest
WO2020109866A1 (en) 2018-11-30 2020-06-04 Genomic Vision Association between integration of viral as hpv or hiv genomes and the severity and/or clinical outcome of disorders as hpv associated cervical lesions or aids pathology
CN112877366A (zh) * 2020-03-10 2021-06-01 广州复能基因有限公司 用于检测来自dna或rna生物体的样品靶标的可掺入参照标准品
WO2021236116A1 (en) * 2020-05-20 2021-11-25 Delahoussaye Kevin Antiviral medicinal template
EP4251766A1 (en) 2020-11-25 2023-10-04 Genomic Vision Physical characterization of telomeres

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542096A (en) * 1983-02-25 1985-09-17 President And Fellows Of Harvard College Detecting rearranged human c-myc DNA fragments associated with oncogenes
US5200313A (en) * 1983-08-05 1993-04-06 Miles Inc. Nucleic acid hybridization assay employing detectable anti-hybrid antibodies
NZ209307A (en) 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
GR862472B (en) 1986-09-30 1986-10-09 Elliniko Institouto Paster Determination of antibodies specific of hsv-1 herpes or hsv-2 in human serum with the elisa technic using the specific antigen of hsv-1 or hsv-2 type in semi - clean form
FR2716263B1 (fr) 1994-02-11 1997-01-17 Pasteur Institut Procédé d'alignement de macromolécules par passage d'un ménisque et applications dans un procédé de mise en évidence, séparation et/ou dosage d'une macromolécule dans un échantillon.
JPH07250699A (ja) * 1994-03-11 1995-10-03 Toyobo Co Ltd ヒトヘルペスウイルスを分別検出する方法およびその試薬
FR2737574B1 (fr) 1995-08-03 1997-10-24 Pasteur Institut Appareillage d'alignement parallele de macromolecules et utilisation
FR2755149B1 (fr) 1996-10-30 1999-01-15 Pasteur Institut Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
US6248537B1 (en) 1999-05-28 2001-06-19 Institut Pasteur Use of the combing process for the identification of DNA origins of replication
ATE349533T1 (de) 2000-06-29 2007-01-15 Corixa Corp Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
US6852491B2 (en) * 2001-09-04 2005-02-08 Abbott Laboratories Amplification and detection reagents for HIV-1
US20030143549A1 (en) * 2002-01-29 2003-07-31 Eastman Kodak Company Method for DNA sequencing and gene identification
AU2003285908A1 (en) 2002-10-18 2004-05-04 University Of Utah Research Foundation Diagnosis and treatment of herpes simplex virus diseases
FR2872910B1 (fr) * 2004-07-07 2006-10-13 Nanoraptor Sa Composant optique pour l'observation d'un echantillon nanometrique, systeme comprenant un tel composant, procede d'analyse mettant en oeuvre ce composant, et leurs applications
EP1851331B1 (fr) * 2005-02-25 2016-02-24 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Procede et dispositif pour separer des cibles moleculaires dans un melange complexe
WO2007047759A1 (en) * 2005-10-17 2007-04-26 The Trustees Of The University Of Pennsylvania Autonomously replicating kshv cis-acting elements
US7985542B2 (en) 2006-09-07 2011-07-26 Institut Pasteur Genomic morse code
EP2175037B1 (en) 2008-09-26 2017-10-11 Genomic Vision Method for analyzing D4Z4 tandem repeat arrays of nucleic acid and kit therefore

Also Published As

Publication number Publication date
WO2011132078A3 (en) 2012-01-26
US20110287423A1 (en) 2011-11-24
CN105734170A (zh) 2016-07-06
US20230127554A1 (en) 2023-04-27
EP2561104A2 (en) 2013-02-27
EP3000900B1 (en) 2018-02-28
WO2011132078A2 (en) 2011-10-27
BR112012027151A8 (pt) 2018-06-26
EP3000900A1 (en) 2016-03-30
CN103069010A (zh) 2013-04-24
JP2017184745A (ja) 2017-10-12
IL222545A0 (en) 2012-12-31
CN103069010B (zh) 2016-02-24
EP2561104B1 (en) 2015-11-04
BR112012027151A2 (pt) 2017-07-18
CA2796294C (en) 2019-03-26
MX2012012352A (es) 2013-06-28
ES2668802T3 (es) 2018-05-22
US20160047006A1 (en) 2016-02-18
US20190345570A1 (en) 2019-11-14
CA2796294A1 (en) 2011-10-27
IL250727A0 (en) 2017-04-30
IL222545A (en) 2017-03-30
JP2013524806A (ja) 2013-06-20

Similar Documents

Publication Publication Date Title
MX346524B (es) Diagnostico de infecciones virales mediante la deteccion de adn viral genómico e infeccioso mediante compatibilización molecular.
WO2016064894A3 (en) Compositions and methods for detecting an rna virus
BR112013033462A2 (pt) método para a redução de complexidade do genoma e detecção de polimorfismo
WO2016203267A3 (en) Diagnosis and treatment of infectious disease
MX2015004191A (es) Metodos y reactivos para la deteccion, cuantificacion y serotipado de virus del dengue.
IN2014DN03409A (es)
WO2009061640A3 (en) Hepatitis b virus (hbv) specific oligonucleotide sequences
WO2009017743A3 (en) Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
WO2010099378A3 (en) Assay for detection of human parvovirus nucleic acid
EA201491821A1 (ru) Модифицированные олигонуклеотиды, включающие тиольные функциональные группы, и их применение для детекции нуклеиновых кислот
WO2015127201A8 (en) Hiv-2 nucleic acids and methods of detection
Gu et al. Rapid and specific detection of H3 swine influenza virus using reverse transcription loop‐mediated isothermal amplification method
EP4299767A3 (en) Compositions and methods for detecting hev nucleic acid
JP2014083052A5 (es)
RU2011152586A (ru) ИСПОЛЬЗОВАНИЕ ГЕНОВ СИСТЕМ ТОКСИН-АНТИТОКСИН RelBE И MazEF ДЛЯ ВИДОВОЙ И ШТАММОВОЙ ИДЕНТИФИКАЦИИ ЛАКТОБАЦИЛЛ
MY184600A (en) Real-time viral detection method and kit for infectious hypodermal and haematopoietic necrosis virus
RU2565554C2 (ru) СПОСОБ ДИФФЕРЕНЦИАЦИИ БИОВАРОВ И ГЕНОВАРИАНТОВ ШТАММОВ Yersinia pestis ОСНОВНОГО ПОДВИДА С ПОМОЩЬЮ ПОЛИМЕРАЗНОЙ ЦЕПНОЙ РЕАКЦИИ
BR112012004847A2 (pt) genoma bohv-4 mutante, vírus bohv-4 mutante, vacina, uso de um vírus bohv-4 mutante, célula, método para a produção de um genoma bohv-4 mutante ou um vírus bohv-4 mutante, e, kit de teste de diagnóstico para diferenciar animais infectados.
CN105803109A (zh) 一种利用等温核酸扩增技术快速检测黄热病毒的方法
WO2012047897A3 (en) Processes and compositions for detecting human papilloma virus types
WO2017116219A3 (fr) Amorces et sondes pour l'amplification, la détection et/ou la quantification du génome du virus de l'hépatite c
PH12014000009A1 (en) Molecular diagnostics for white spot virus for prawns and other crustaceans
EP1895018A3 (de) Verfahren und Mittel zum Nachweis von humanen Papillomaviren
RU2015127016A (ru) Способ выявления РНК вируса гепатита Е в клинических образцах от людей и в образцах внешней среды
Vasin et al. Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses

Legal Events

Date Code Title Description
FG Grant or registration